aetiological category for unexplained (or idiopathic) cardiomyopathy would improve the clinical utility of the MOGE(s) scheme. 1 The authors of the scheme completely agree, and reiterate that the classification system (or nosology) is flexible, conveniently expandable, and allows easy modification of the MOGE(S) online app. 4 The first update to the app has been already proposed to improve the description of arrhythmogenic right ventricular cardiomyopathy. 5 EMF might provide a paradigmatic example of the flexibility of the MOGE(S) nosology and associated app. EMF is esti mated to be the underlying cause of 20% of heart failure in the areas of Africa in which EMF is endemic, and is known to be the second leading cause of hospital admissions for acquired cardiovascular disease in chil dren and young adults, after rheumatic heart disease. 6 However, the aetiology of EMF remains elusive. Several hypotheses have been proposed, such as cardiotoxicity of eosinophils and hypereosinophilia ( Eo), often associated with parasitic infectious aetiology (schistosomiasis, Loa loa micro filaria, filariasis, or malaria), autoimmunity (high titres of malarial antibodies, hyper immune malarial splenomegaly, raised anti streptolysin titres in patients with EMF), genetic or ethnic predisposition (high incidence among particular ethnic groups in some countries), diet (tuber cassava, tapioca) in association with extreme depri vation of proteins (tryptophan deficiency), and geochemical and climate character istics (caesium derived from monazite soils). [7] [8] [9] [10] [11] [12] [13] [14] Although none of these factors has been proven to cause EMF, the MOGE(S) nosology can be invoked as follows.
The condition can manifest as isolated or dominant left ventricular (LV) EMF, iso lated or dominant right ventricular (RV) EMF, or biventricular (RV + LV) EMF, and can be stated as such in the MOGE(S) description. MOGE(S) can also describe the organ involvement in addition to the heart (H), such as liver involvement (H + L), or Eo. Aetiology can be listed as being known (K), suspected (S), or unknown (U). If known or suspected, the aetiology can be coupled with description of the injuri ous agent. Although isolated EMF is easily described by MOGE(S), the presence of Eo goes beyond the cardiac evaluation and requires haematological and immuno logical investigation and classification. Various classifications of Eo disorders and associated syndromes have been formu lated in the past, and the Year 2011 Working Conference on Eosinophil Disorders and Syndromes refined the criteria and defini tions. 15 The description of EMF with Eo, with or without involvement of organs other than the heart (such as lungs, skin, liver, gastro intestinal tract, pancreas, or kidneys) CORRESPONDENCE requires a multidisciplinary diagnostic workup, starting with elucidation of the cause of Eo. The important information for treatment is the identification of fusion genes involving PDGFRA, PDGFRB, and FGFR1. MOGE(S) can describe the mutations in oncogenic tyrosine kinase receptors in the aetiology section, or their absence (negative), or the lack of information (not tested).
The examples in Box 1 were gener ated using the MOGE(S) app. 4 Therefore, MOGE(S) and its app can readily provide a description for any type of cardiomyopathy, with the advantage of integrating important information that can constitute the basis for a novel, worldwide epidemiology to describe diseases, not only on the basis of their clinical phenotypes, but also according to their aetiology.
